Nuvation Bio (NUVB) Gains from Investment Securities (2023 - 2025)
Historic Gains from Investment Securities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$612000.0.
- Nuvation Bio's Gains from Investment Securities fell 1482.18% to -$612000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 413588.52%. This contributed to the annual value of $6.0 million for FY2024, which is 39580.59% up from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Gains from Investment Securities is -$612000.0, which was down 1482.18% from -$454000.0 recorded in Q2 2025.
- Over the past 5 years, Nuvation Bio's Gains from Investment Securities peaked at $5.8 million during Q4 2024, and registered a low of -$1.1 million during Q2 2024.
- Its 3-year average for Gains from Investment Securities is $796600.0, with a median of -$262500.0 in 2023.
- Data for Nuvation Bio's Gains from Investment Securities shows a peak YoY increase of 112746.48% (in 2024) and a maximum YoY decrease of 52830.19% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Nuvation Bio's Gains from Investment Securities stood at -$383000.0 in 2023, then soared by 1618.54% to $5.8 million in 2024, then plummeted by 110.52% to -$612000.0 in 2025.
- Its Gains from Investment Securities was -$612000.0 in Q3 2025, compared to -$454000.0 in Q2 2025 and $3.7 million in Q1 2025.